Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
Eur J Med Chem
; 182: 111665, 2019 Nov 15.
Article
en En
| MEDLINE
| ID: mdl-31494469
ABSTRACT
A series of novel derivatives of artemisinin-4-(arylamino)quinazoline have been designed and synthesized, and most of them showing potent in vitro cytotoxic activity against HCT116 and WM-266-4â¯cell lines. Compound 32 was the most active derivative against HCT116â¯cell line with an IC50 of 110â¯nM, and significantly improved the antitumor activity of the parent compounds dihydroartemisinin (DHA) (IC50â¯=â¯2.85⯵M) and Gefitinib (IC50â¯=â¯19.82⯵M). In vivo HCT116 xenografts assay showed that compound 32 exhibited potent antitumor activity with obvious tumor growth delay and tumor shrunken after 18 days treatment on xenografted mice, and especially without loss of body weight. Our results indicate that compounds 32 may represent a safe, novel structural lead for developing new chemotherapy of colorectal cancer.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Colorrectales
/
Diseño de Fármacos
/
Artemisininas
/
Antineoplásicos
Idioma:
En
Revista:
Eur J Med Chem
Año:
2019
Tipo del documento:
Article